Uncategorized

Niowave, fresh from Novartis deal, starts building $75M radioisotope plant

Published

on

Having secured deals with AstraZeneca and Novartis, Niowave is constructing a second facility to meet rising demand for actinium-225, which can be used to develop next-generation radiopharmaceuticals.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version